Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
96.31m
Last Price
$2.99
52-Week Range
$2.07 - $4.20
08/29/2025 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808